{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:01:31Z","timestamp":1791500491658,"version":"4.3.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.kint.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T04:04:50Z","timestamp":1546229090000},"page":"25-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Levamisole for children with nephrotic syndrome: new evidence for the use of an \u201cold\u201d drug"],"prefix":"10.1016","volume":"95","author":[{"given":"Marina","family":"Vivarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10141","key":"10.1016\/j.kint.2018.10.008_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.kint.2018.10.008_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00467-017-3677-5","article-title":"Immunology of idiopathic nephrotic syndrome","volume":"33","author":"Colucci","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2018.10.008_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","article-title":"Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","volume":"95","author":"Sinha","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.008_bib4","doi-asserted-by":"crossref","unstructured":"Querfeld U, Weber LT. Mycophenolate mofetil for sustained remission in nephrotic syndrome [e-pub ahead of print]. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-018-3970-y. Accessed October 29,\u00a02018.","DOI":"10.1007\/s00467-018-3970-y"},{"issue":"10","key":"10.1016\/j.kint.2018.10.008_bib5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.kint.2018.10.008_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/MOH.0000000000000393","article-title":"Cocaine\/levamisole-associated autoimmune syndrome: a disease\u00a0of neutrophil-mediated autoimmunity","volume":"25","author":"Cascio","year":"2018","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.kint.2018.10.008_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","article-title":"A\u00a0randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome","volume":"93","author":"Gruppen","year":"2018","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.kint.2018.10.008_bib8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1046\/j.1365-2133.1999.02833.x","article-title":"Purpura\u00a0of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children","volume":"140","author":"Rongioletti","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.kint.2018.10.008_bib9","doi-asserted-by":"crossref","unstructured":"Dartevel A, Chaigne B, Moachon L, et\u00a0al. Levamisole-induced vasculopathy: a systematic review [e-pub ahead of print]. Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.07.010. Accessed October 29,\u00a02018.","DOI":"10.1016\/j.semarthrit.2018.07.010"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818307506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:52:50Z","timestamp":1758761570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818307506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0085253818307506"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.008","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levamisole for children with nephrotic syndrome: new evidence for the use of an \u201cold\u201d drug","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.08.039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}